Common use of License Template; Execution After Option Exercise Clause in Contracts

License Template; Execution After Option Exercise. (a) Within [***] days of the Effective Date, the Parties shall negotiate [***] and use [***] to agree upon a form of agreement template (“License Template”) to be used in connection with Spyre’s exercise of its Option with respect to a given Research Program. The License Template will be consistent with the economic and other terms set forth in Exhibit B, and upon mutual agreement by the Parties on the form of the License Template, will be attached to this Agreement and replace the terms on the existing Exhibit B. If the Parties are unable to reach agreement on the definitive terms of the License Template within such [***] period, the matter will be resolved in accordance with Section 11.7. (b) Within [***] days of Spyre’s exercise of its Option with respect to a Research Program as set forth in Section 4.3, the Parties shall use [***] to finalize and execute a definitive written agreement consistent with the License Template (the “License Agreement”) with respect to such Research Program.

Appears in 2 contracts

Samples: Antibody Discovery and Option Agreement (Spyre Therapeutics, Inc.), Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)

AutoNDA by SimpleDocs

License Template; Execution After Option Exercise. (a) Within [***] days of the Effective Date, the Parties shall negotiate [***] and use [***] to agree upon a form of agreement template (“License Template”) to be used in connection with Spyre’s exercise of its Option with respect to a given Research Program. The License Template will be consistent with the economic and other terms set forth in Exhibit B, and upon mutual agreement by the Parties on the form of the License Template, will be attached to this Agreement and replace the terms on the existing Exhibit B. If the Parties are unable to reach agreement on the definitive terms of the License Template within such [***] period, the matter will be resolved in accordance with Section 11.7‎11.7. (b) Within [***] ]days of Spyre’s exercise of its Option with respect to a Research Program as set forth in Section 4.3‎4.3, the Parties shall use [***] to finalize and execute a definitive written agreement consistent with the License Template (the “License Agreement”) with respect to such Research Program.

Appears in 1 contract

Samples: Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)

License Template; Execution After Option Exercise. (a) Within [***] days of the Effective Date, the Parties shall negotiate [***] and use [***] to agree upon a form of agreement template (“License Template”) to be used in connection with SpyreApogee’s exercise of its Option with respect to a given Research Program. The License Template will be consistent with the economic and other terms set forth in Exhibit BA, and upon mutual agreement by the Parties on the form of the License Template, will be attached to this Agreement and replace the terms on the existing Exhibit B. If the Parties are unable to reach agreement on the definitive terms of the License Template within such [***] period, the matter will be resolved in accordance with Section 11.7. (b) Within [***] days of SpyreApogee’s exercise of its Option with respect to a Research Program as set forth in Section 4.3, the Parties shall use [***] to finalize and execute a definitive written agreement consistent with the License Template (the “License Agreement”) with respect to such Research Program.

Appears in 1 contract

Samples: Antibody Discovery and Option Agreement (Apogee Therapeutics, Inc.)

AutoNDA by SimpleDocs

License Template; Execution After Option Exercise. (a) Within [***] days of the Effective Date, the Parties shall negotiate [***] and use [***] to agree upon a form of agreement template (“License Template”) to be used in connection with SpyreXxxxx’s exercise of its Option with respect to a given Research Program. The License Template Option, which will be consistent with the economic and other terms set forth in Exhibit B, and upon mutual agreement by the Parties on the form of the such License Template, will be attached to this Agreement and replace the terms on the existing Exhibit B. If the Parties are unable to reach agreement on the definitive terms of the either License Template within such [***] period, the matter will be resolved in accordance with Section 11.7‎11.7 unless the Parties mutually agree to resolve the matter otherwise. (b) Within [***] days of SpyreXxxxx’s exercise of its Option with respect to a Research Program as set forth in Section 4.3‎4.3, subject to any extension as mutually agreed by the Parties, the Parties shall use [***] to finalize and execute a definitive written agreement consistent with the License Template (the “License Agreement”) with respect to such Research Program.

Appears in 1 contract

Samples: Antibody Discovery and Option Agreement (ARCA Biopharma, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!